Outcome of surgical resection of pulmonary metastasis from urinary tract transitional cell carcinoma

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 1, 2010, Pages 60-64

  Kanzaki, Ryu ^a   Higashiyama, Masahiko ^a   Fujiwara, Ayako ^a   Tokunaga, Toshiteru ^a   Maeda, Jun ^a   Okami, Jiro ^a   Nishimura, Kazuo ^a   Kodama, Ken ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Lung; Metastasectomy; Urothelial cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LUNG RESECTION; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; URINARY TRACT SURGERY; ADJUVANT CHEMOTHERAPY; CARCINOMA, TRANSITIONAL CELL; DISEASE FREE SURVIVAL; JAPAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; TIME; TREATMENT OUTCOME; URINARY TRACT CANCER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 77954545267     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.236687     Document Type: Article

References (15)

1. Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C. Guidelines on bladder cancer. Eur Urol 2002;41:105-112.
2. Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985;133:403-407.
3. Sternberg CN. The treatment of advanced bladder cancer. Ann Oncol 1995;6:113-126.
4. Shah JB, McKiernan JM. Novel therapeutics in the treatment of bladder cancer. Curr Opin Urol 2004;14:287-293.
5. Barney JC, Churchill EJ. Adenocarcinoma of the kidney with metastases to the lung: cured nephrectomy and lobectomy. J Urol 1939;42:269-276.
6. Allen MS, Putnam JB Jr. Secondary tumors of the lung. In: Shields T, editor. General thoracic surgery, seventh edition. Vol. 2. Philadelphia: Lippincott Williams and Wilkins, 2009:1619-1646.
7. Dodd PM, McCaffrey JA, Herr H, Mazumdar M, Bacik J, Higgins G, Boyle MG, Scher HI, Bajorin DF. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol 1999;17:2546-2552.
8. Kodama K, Doi O, Higashiyama M, Tatsuta M, Iwanaga T. Surgical management of lung metastases. Usefulness of resection with the neodymium: yttrium-aluminum-garnet laser with median sternotomy. J Thorac Cardiovasc Surg 1991;101:901-908.
9. Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009;55:815-825.
10. Cowles RS, Johnson DE, McMurtrey MJ. Long-term results following thoracotomy for metastatic bladder cancer. Urology 1982;20:390-392.
11. Miller RS, Freiha FS, Reese JH, Ozen H, Torti FM. Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol 1993;150:65-69.
12. Otto T, Krege S, Suhr J, Rubben H. Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. Urology 2001;57:55-59.
13. Siefker-Radtke AO, Walsh GL, Pisters LL, Shen Y, Swanson DA, Logothetis CJ, Millikan RE. Is there a role for surgery in the management of metastatic urothelial cancer? The M.D. Anderson experience. J Urol 2004;171:145-148.
14. Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Suzuki S, Nonomura K. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 2007;52:1106-1113.
15. Lehmann J, Suttmann H, Albers P, Volkmer B, Gschwend JE, Fechner G, Spahn M, Heidenreich A, Odenthal A, Seif C, Nurnberg N, Wulfing C, Greb C, Kälble T, Grimm MO, Fieseler CF, Krege S, Retz M, Schulte-Baukloh H, Gerber M, Hack M, Kamradt J, Stöckle M. Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol 2009;55:1293-1299.